Full Text of PDF (558k)
Article in Japanese
Abstract
Review
Should thoracoscopic total pleural covering be recommended to prevent the recurrence of pneumothorax associated with lymphangioleiomyomatosis?
Mie Hayashidaa,b Yosuke Wadac Yoshiaki Kitaguchic Masanori Yasuoc Masayuki Hanaokaa,c Kuniaki Seyamaa,d Yoshikazu Inouea,e Koichiro Tatsumia,f
aThe Intractable Respiratory Diseases and Pulmonary Hypertension Research Group of the Japanese Ministry of Health, Labor and Welfare
bDepartment of Internal Medicine, Division of Respiratory Medicine, Infectious Diseases and Allergy, Shinshu University Hospital
cFirst Department of Internal Medicine, Shinshu University School of Medicine
dDivision of Respiratory Medicine, Juntendo University, Faculty of Medicine and Graduate School of Medicine
eClinical Research Center, National Hospital Organization Kinki-Chuo Chest Medical Center
fDepartment of Respirology, Graduate School of Medicine, Chiba University
ABSTRACT
Lymphangioleiomyomatosis (LAM) is frequently associated with pneumothorax, often recurrent and intractable. The Official Clinical Practice Guidelines from the American Thoracic Society/Japanese Respiratory Society recommend performing pleurodesis when the first episode of pneumothorax occurs. Thoracoscopic total pleural covering has been reported as a new treatment for pneumothorax associated with LAM and it is therefore of clinical importance to establish the positioning of this treatment. Qualitative systematic reviews and recommendations have been created according to the Minds Handbook for Clinical Practice Guideline Development.
KEYWORDS
Lymphangioleiomyomatosis (LAM) Pneumothorax Total pleural covering (TPC) Systematic review Minds
Received 17 Jan 2020 ／ Accepted 13 Feb 2020
AJRS, 9(3): 151-159, 2020
Copyright © The Japanese Respiratory Society All Rights Reserved.